Who is sponsoring NCT05843032?

NCT05843032 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05843032?

Interventions in NCT05843032: 3D ultrasound, MRI, resected specimen examination by surgeon.

What condition does NCT05843032 study?

NCT05843032 studies Squamous Cell Carcinoma, Tongue SCC, Head and Neck Cancer.

Is NCT05843032 still recruiting?

NCT05843032 is currently status unknown. Last updated 9 May 2023.

Last reviewed 2023-05-09 · How we verify

NCT05843032

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment

Status unknown NA Last updated 9 May 2023

What this trial tests

NA trial testing 3D ultrasound, MRI, resected specimen examination by surgeon in Squamous Cell Carcinoma in 27 participants. Status unknown.

Timeline

15 May 2023

Primary endpoint
30 December 2023

15 February 2024

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	27
Start date	15 May 2023
Primary completion	30 December 2023
Estimated completion	15 February 2024
Sites	1 location across Denmark

Drugs / interventions tested

3D ultrasound, MRI, resected specimen examination by surgeon

Conditions studied

Squamous Cell Carcinoma — all drugs for Squamous Cell Carcinoma →
Tongue SCC — all drugs for Tongue SCC →
Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Squamous Cell Carcinoma or Tongue SCC. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current protocol, application of 3D ex-vivo ultrasound, MRI, and clinical evaluation (palpation and examination) by the surgeon is proposed to analyze the margin status in tongue squamous cell carcinoma and correlate the results to the histopathology findings.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

3D Ultrasound and MRI in Assessing Resection Margins during Tongue Cancer Surgery: A Research Protocol for a Clinical Diagnostic Accuracy Study.
Makouei F, Agander TK, Ewertsen C, Søndergaard Svendsen MB, et al · · 2023 · cited 4× · PMID 37754938 · DOI 10.3390/jimaging9090174

Verify or expand the search:

Other recruiting trials for Squamous Cell Carcinoma

Currently open trials in the same condition.

NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
NCT07223424 — Patient Preference for Subcutaneous vs. Intravenous Immune Therapy · Phase 2 · recruiting
NCT07095608 — Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain · NA · recruiting
NCT06996249 — Prospective Data Collection Initiative on Thoracic Malignancies · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05843032 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 9 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05843032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing